• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于图像的β-肾上腺素汗液速率测定法可捕捉到最小的囊性纤维化跨膜电导调节剂功能。

Image-based β-adrenergic sweat rate assay captures minimal cystic fibrosis transmembrane conductance regulator function.

机构信息

Children's Hospital Los Angeles, University of Southern California (USC), Los Angeles, CA, USA.

Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.

出版信息

Pediatr Res. 2020 Jan;87(1):137-145. doi: 10.1038/s41390-019-0503-8. Epub 2019 Jul 25.

DOI:10.1038/s41390-019-0503-8
PMID:31344706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6962560/
Abstract

BACKGROUND

There is a need to prognosticate the severity of cystic fibrosis (CF) detected by newborn screening (NBS) by early assessment of CF transmembrane conductance regulator (CFTR) protein function. We introduce novel instrumentation and protocol for evaluating CFTR activity as reflected by β-adrenergically stimulated sweat secretion.

METHODS

A pixilated image sensor detects sweat rates. Compounds necessary for maximum sweat gland stimulation are applied by iontophoresis, replacing ID injections. Results are compared to a validated β-adrenergic assay that measures sweat secretion by evaporation (evaporimetry).

RESULTS

Ten healthy controls (HC), 6 heterozygous (carriers), 5 with CFTR-related metabolic syndrome (CRMS)/CF screen-positive, inconclusive diagnosis (CFSPID), and 12 CF individuals completed testing. All individuals with minimal and residual function CFTR mutations had low ratios of β-adrenergically stimulated sweat rate to cholinergically stimulated sweat rate (β/chol) as measured by either assay.

CONCLUSIONS

β-Adrenergic assays quantitate CFTR dysfunction in the secretory pathway of sweat glands in CF and CRMS/CFSPID populations. This novel image-sensor and iontophoresis protocol detect CFTR function with minimal and residual function and is a feasible test for young children because it is insensible to movement and it decreases the number of injections. It may also assist to distinguish between CF and CRMS/CFSPID diagnosis.

摘要

背景

通过早期评估囊性纤维化跨膜电导调节因子(CFTR)蛋白功能,对新生儿筛查(NBS)检测到的囊性纤维化(CF)的严重程度进行预测是必要的。我们引入了一种新的仪器和方案,用于评估 CFTR 活性,其反映在β-肾上腺素能刺激的汗液分泌上。

方法

像素图像传感器检测汗液速率。通过离子电渗法应用刺激最大汗腺所需的化合物,替代 ID 注射。结果与验证的β-肾上腺素能测定法(蒸发法)测量的汗液分泌进行比较。

结果

10 名健康对照(HC)、6 名杂合子(携带者)、5 名 CFTR 相关代谢综合征/CF 筛查阳性、不确定诊断(CFSPID)和 12 名 CF 个体完成了测试。所有具有最小和残余 CFTR 突变功能的个体,无论使用哪种测定法,β-肾上腺素能刺激的汗液率与胆碱能刺激的汗液率(β/胆碱)的比值均较低。

结论

β-肾上腺素能测定法定量测定 CF 和 CRMS/CFSPID 人群的汗液腺分泌途径中 CFTR 功能障碍。这种新的图像传感器和离子电渗方案可以检测最小和残余功能的 CFTR 功能,并且对于幼儿来说是可行的测试,因为它对运动不敏感,并且减少了注射次数。它还可能有助于区分 CF 和 CRMS/CFSPID 诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/547992b1becc/nihms-1534865-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/744808a01543/nihms-1534865-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/2b7f1428e8f8/nihms-1534865-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/47ca486c622c/nihms-1534865-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/2dc263e36830/nihms-1534865-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/baaf193e9b64/nihms-1534865-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/547992b1becc/nihms-1534865-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/744808a01543/nihms-1534865-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/2b7f1428e8f8/nihms-1534865-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/47ca486c622c/nihms-1534865-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/2dc263e36830/nihms-1534865-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/baaf193e9b64/nihms-1534865-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6962560/547992b1becc/nihms-1534865-f0006.jpg

相似文献

1
Image-based β-adrenergic sweat rate assay captures minimal cystic fibrosis transmembrane conductance regulator function.基于图像的β-肾上腺素汗液速率测定法可捕捉到最小的囊性纤维化跨膜电导调节剂功能。
Pediatr Res. 2020 Jan;87(1):137-145. doi: 10.1038/s41390-019-0503-8. Epub 2019 Jul 25.
2
β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis.β-肾上腺素汗腺分泌作为囊性纤维化的诊断测试。
Am J Respir Crit Care Med. 2012 Oct 15;186(8):732-9. doi: 10.1164/rccm.201205-0922OC. Epub 2012 Aug 2.
3
Iontophoretic beta-adrenergic stimulation of human sweat glands: possible assay for cystic fibrosis transmembrane conductance regulator activity in vivo.人汗腺的离子电渗β-肾上腺素能刺激:体内囊性纤维化跨膜传导调节因子活性的可能检测方法。
Exp Physiol. 2008 Aug;93(8):969-81. doi: 10.1113/expphysiol.2008.042283. Epub 2008 Apr 25.
4
β-adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?儿童疑似囊性纤维化诊断中β-肾上腺素能汗液试验:我们是否需要新的参考范围?
Pediatr Pulmonol. 2023 Jan;58(1):187-196. doi: 10.1002/ppul.26179. Epub 2022 Oct 17.
5
A simplified cyclic adenosine monophosphate-mediated sweat rate test for quantitative measure of cystic fibrosis transmembrane regulator (CFTR) function.一种用于定量测量囊性纤维化跨膜传导调节因子(CFTR)功能的简化环磷酸腺苷介导的出汗率测试。
J Pediatr. 2000 Dec;137(6):849-55. doi: 10.1067/mpd.2000.109198.
6
Low Beta-Adrenergic Sweat Responses in Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome Children.囊性纤维化及囊性纤维化跨膜传导调节因子相关代谢综合征患儿的低β-肾上腺素能汗液反应
Pediatr Allergy Immunol Pulmonol. 2017 Mar 1;30(1):2-6. doi: 10.1089/ped.2016.0662.
7
Needle-free iontophoresis-driven β-adrenergic sweat rate test.无针电渗驱动β肾上腺素汗液速率测试。
J Cyst Fibros. 2022 May;21(3):407-415. doi: 10.1016/j.jcf.2021.08.012. Epub 2021 Sep 4.
8
Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis.汗腺生物电化学在囊性纤维化中存在差异:这是一个用于潜在诊断和评估囊性纤维化跨膜传导调节因子(CFTR)功能的新概念。
Thorax. 2009 Nov;64(11):932-8. doi: 10.1136/thx.2009.115295. Epub 2009 Sep 3.
9
Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.囊性纤维化跨膜传导调节因子相关代谢综合征及囊性纤维化筛查呈阳性、诊断不确定
J Pediatr. 2017 Feb;181S:S45-S51.e1. doi: 10.1016/j.jpeds.2016.09.066.
10
The diagnosis of cystic fibrosis.囊性纤维化的诊断。
Presse Med. 2017 Jun;46(6 Pt 2):e97-e108. doi: 10.1016/j.lpm.2017.04.010. Epub 2017 May 31.

引用本文的文献

1
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators.高效CFTR调节剂时代囊性纤维化个性化医疗的进展
Mol Cell Pediatr. 2025 May 5;12(1):6. doi: 10.1186/s40348-025-00194-0.
2
Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis.了解 CFTR 功能:囊性纤维化相关测试和调节剂治疗的综合综述。
Cell Biochem Biophys. 2024 Mar;82(1):15-34. doi: 10.1007/s12013-023-01200-w. Epub 2023 Dec 4.
3
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24.

本文引用的文献

1
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects.囊性纤维化、携带者和健康受试者的比率汗液分泌光学测试。
J Cyst Fibros. 2018 Mar;17(2):186-189. doi: 10.1016/j.jcf.2017.12.003. Epub 2017 Dec 29.
2
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.Tezacaftor-Ivacaftor 治疗纯合子 Phe508del 突变型囊性纤维化患者的疗效
N Engl J Med. 2017 Nov 23;377(21):2013-2023. doi: 10.1056/NEJMoa1709846. Epub 2017 Nov 3.
3
Low Beta-Adrenergic Sweat Responses in Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome Children.
CFTR 调节剂可恢复表达复杂等位基因 p.[R74W;V201M;D1270N]/dele22_24 的类器官中 CFTR 的活性。
Int J Mol Sci. 2023 Mar 8;24(6):5199. doi: 10.3390/ijms24065199.
4
Skin-Interfaced Wearable Sweat Sensors for Precision Medicine.用于精准医疗的皮肤界面可穿戴汗液传感器。
Chem Rev. 2023 Apr 26;123(8):5049-5138. doi: 10.1021/acs.chemrev.2c00823. Epub 2023 Mar 27.
5
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry.美国患者注册中心囊性纤维化患者的囊性纤维化筛查阳性、不确定诊断基因型。
Ann Am Thorac Soc. 2023 Apr;20(4):523-531. doi: 10.1513/AnnalsATS.202201-024OC.
6
β-adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?儿童疑似囊性纤维化诊断中β-肾上腺素能汗液试验:我们是否需要新的参考范围?
Pediatr Pulmonol. 2023 Jan;58(1):187-196. doi: 10.1002/ppul.26179. Epub 2022 Oct 17.
7
Assays of CFTR Function In Vitro, Ex Vivo and In Vivo.体外、离体和体内 CFTR 功能测定。
Int J Mol Sci. 2022 Jan 27;23(3):1437. doi: 10.3390/ijms23031437.
8
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis.对一名患有急性复发性胰腺炎的G542X+/- IVS8Tn:T7/9患者进行囊性纤维化跨膜传导调节因子功能评估。
World J Clin Cases. 2019 Nov 26;7(22):3757-3764. doi: 10.12998/wjcc.v7.i22.3757.
囊性纤维化及囊性纤维化跨膜传导调节因子相关代谢综合征患儿的低β-肾上腺素能汗液反应
Pediatr Allergy Immunol Pulmonol. 2017 Mar 1;30(1):2-6. doi: 10.1089/ped.2016.0662.
4
Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.囊性纤维化跨膜传导调节因子相关代谢综合征及囊性纤维化筛查呈阳性、诊断不确定
J Pediatr. 2017 Feb;181S:S45-S51.e1. doi: 10.1016/j.jpeds.2016.09.066.
5
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.囊性纤维化的诊断:来自囊性纤维化基金会的共识指南
J Pediatr. 2017 Feb;181S:S4-S15.e1. doi: 10.1016/j.jpeds.2016.09.064.
6
Diagnosis of Cystic Fibrosis in Screened Populations.筛查人群中囊性纤维化的诊断
J Pediatr. 2017 Feb;181S:S33-S44.e2. doi: 10.1016/j.jpeds.2016.09.065.
7
Evaporimeter and Bubble-Imaging Measures of Sweat Gland Secretion Rates.汗腺分泌率的蒸发计和气泡成像测量法。
PLoS One. 2016 Oct 21;11(10):e0165254. doi: 10.1371/journal.pone.0165254. eCollection 2016.
8
Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.通过对加利福尼亚州囊性纤维化新生儿筛查呈阳性的儿童进行测序鉴定出的良性和有害的囊性纤维化跨膜传导调节因子突变
PLoS One. 2016 May 23;11(5):e0155624. doi: 10.1371/journal.pone.0155624. eCollection 2016.
9
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.针对携带Phe508del CFTR纯合突变的囊性纤维化患者使用鲁马卡托-依伐卡托。
N Engl J Med. 2015 Oct 29;373(18):1783-4. doi: 10.1056/NEJMc1510466.
10
Clinical expression of patients with the D1152H CFTR mutation.D1152H CFTR 突变患者的临床表型。
J Cyst Fibros. 2015 Jul;14(4):447-52. doi: 10.1016/j.jcf.2014.12.012. Epub 2015 Jan 10.